Ubs Asset Management Americas Inc Agios Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 217,402 shares of AGIO stock, worth $8.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
217,402
Previous 147,276
47.62%
Holding current value
$8.89 Million
Previous $4.32 Million
67.56%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AGIO
# of Institutions
236Shares Held
61.8MCall Options Held
297KPut Options Held
235K-
Farallon Capital Management LLC San Francisco, CA5.77MShares$236 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$232 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$199 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$147 Million2.72% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.33MShares$95.1 Million0.65% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.24B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...